GlobalData provides unique and market-leading data and insights into the oncology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

NEW T-Cell Lymphomas: Epidemiology Forecast to 2030

  • $3,995
  • January 2022
TCL are a rare type of cancer that form in T-cells and are either indolent (slow-growing) or aggressive. TCL either develops in lymphoid tissues such as the lymph nodes and...

Brain Cancer – Epidemiology Forecast to 2030

  • $3,995
  • December 2021
Primary brain cancer (ICD-10 = C70, C71, C72) is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord,...

Chronic Myeloid Leukemia (CML): Global Drug Forecast and Market Analysis to 2030

  • $10,995
  • December 2021
Chronic myeloid leukemia (CML) is a myeloproliferative cancer resulting from the formation of an abnormal gene; BCR-ABL1. Although CML is now highly survivable due to the availability of multiple effective...

Chronic Myeloid Leukemia: Epidemiology Forecast to 2030

  • $3,995
  • December 2021
Chronic myeloid leukemia (CML) (ICD-10 = C92.1) is a rare cancer of the white blood cells characterized by increased and unregulated growth of myeloid cells originating in the bone marrow...

Glioblastoma Multiforme: Global Drug Forecast and Market Analysis to 2030

  • $10,995
  • December 2021
Glioblastoma multiforme (GBM) is now defined by the WHO 2021 as a diffuse astrocytic glioma with no mutations in IDH genes or histone H3 genes. It is the most common...

Cervical Cancer – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Cervical Cancer - Global Clinical Trials Review, H2, 2021" provides an overview of Cervical Cancer Clinical trials scenario. This report provides top line data relating to...

Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, H2, 2021" provides an overview of Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical trials scenario. This report provides top...

Glioblastoma Multiforme (GBM) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, H2, 2021" provides an overview of Glioblastoma Multiforme (GBM) Clinical trials scenario. This report provides top line data...

Plaque Psoriasis (Psoriasis Vulgaris) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, H2, 2021" provides an overview of Plaque Psoriasis (Psoriasis Vulgaris) Clinical trials scenario. This report provides top...

Thymoma (Thymic Epithelial Tumor) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Thymoma (Thymic Epithelial Tumor) - Global Clinical Trials Review, H2, 2021" provides an overview of Thymoma (Thymic Epithelial Tumor) Clinical trials scenario. This report provides top...